Secondary Metabolites from the Marine Sponge Genus Phyllospongia. by Zhang, Huawei et al.
UC Santa Cruz
UC Santa Cruz Previously Published Works
Title






















Secondary Metabolites from the Marine Sponge
Genus Phyllospongia
Huawei Zhang 1,*, Menglian Dong 1, Hong Wang 1 and Phillip Crews 2
1 School of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China;
baixl2012@163.com (M.D.); yingzhoudengyuan@sina.com (H.W.)
2 Department of Chemistry & Biochemistry, University of California-Santa Cruz, Santa Cruz,
CA 95064, USA; pcrews@ucsc.edu
* Correspondence: hwzhang@zjut.edu.cn; Tel.: +86-571-8832-0903
Academic Editor: Vassilios Roussis
Received: 15 November 2016; Accepted: 29 December 2016; Published: 6 January 2017
Abstract: Phyllospongia, one of the most common marine sponges in tropical and subtropical oceans,
has been shown to be a prolific producer of natural products with a broad spectrum of biological
activities. This review for the first time provides a comprehensive overview of secondary metabolites
produced by Phyllospongia spp. over the 37 years from 1980 to 2016.
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1. Introduction
Marine sponges, as very primitive animals, are widely distributed in the oceans from tropic
to polar regions. Growing evidence indicates that these animals are the most prolific source of
natural products as pharmaceutical leads [1–3]. Marine sponges possess a large variety of secondary
metabolites with diverse chemical structures, such as terpenoids [4], macrolides [5], and sterols [6].
Therefore, it has greatly attracted the attention of natural product chemists and pharmaceutical experts
around the world to carry out chemical research for the new drug discovery.
Phyllospongia (Porifera, Demospongiae, Dictyoceratida, Thorectidae) is one of the most common
marine sponges in tropical and subtropical areas, including the Indian Ocean, the Great Barrier Reef,
Papua New Guinea, the South China Sea, the South Pacific, and the Red Sea. Chemical investigation
of Phyllospongia spp. has been extensively carried out and has given rise to a great array of bioactive
secondary metabolites. In order to better understand and rationally exploit the marine sponge genus
Phyllospongia, relevant research references reported between 1980 and 2016 are summarized in this
review for the first time.
2. Natural Products from Phyllospongia spp.
By 2016, a total of 132 various secondary metabolites (1–132) had been isolated and characterized
from the marine sponge genus Phyllospongia, including P. dendyi, P. (syn. Carteriospongia) foliascens,
P. lamellosa, P. madagascarensis, P. papyracea, Carteriospongia (syn. Phyllospongia) flabellifera, and other
unidentified Phyllospongia spp. (Table 1). In terms of their chemical structures, most Phyllospongia
sponge-derived natural products are sesterterpenoids, especially scalaranes [7], which are classified as
C25 (scalarane), C26 (homoscalarane), and C27 (bishomoscalarane) [8]. Bioassay results indicated that
some chemicals have pronounced biological activities and can be used as lead drugs. These secondary
metabolites are summarized below according to biological origin.
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Table 1. Phyllospongia sponge-derived natural products.
Organism Locality Compound References
Phyllospongia dendyi
the Great Barrier Reef furodendin (1), sesterterpenes (2, 3) [9]
Andaman and Nicobar Islands scalaranes (4–6), sesterterpene (7) [10]








the South China Sea
phylloketal (28), phyllofenone A (29),
phyllofenone B (30), phyllofolactones A–B
(31–32), phyllohemiketals A (33) and B (34),
acetoxy phyllofolactone A (35), phyllactones
A–G (36–42), phyllofolactones C–D (43–44),
phyllofolactone L (45), phyllofenone D–E
(46–47), phyllofolactone F–G (48–49),
carteriofenones A-K (50–60), analogue (61),
phyllofolactone M (62), sterol (63)
[7,15–25]
Papua New Guinea 20,24-dimethylscalaranes (64–70) [26,27]
the Indonesia Sea scalaranes (71–75) [28]
the South Pacific 12-epi-phyllofolactone B (76) [29]
the Great Barrier Reef scalaranes (77–79) [30,31]
unknown furanoterpene (80) [32]
P. lamellosa
the Indo-West Pacific Ocean phyllolactones A–E (81–85) [33]
the Egyptian Red Sea phyllospongins A–E (86–90),sesterterpenes (76, 91, 92) [8]
P. madagascarensis Northern Madagascar sesterterpenes (93–95) [34]
P. papyracea
Hainan Island scalaranes (96–98) [35]
Papua New Guinea bishomoscalarane sesterterpenes (99–104) [36]
Sangihe Island phyllactone H (105) [37]
C. (syn. P.) flabellifera the South Pacific Ocean flabelliferins A (106) and B (107) [38]
the Great Barrier Reef sesterterpenoid (108) [39]
Unclassified P. spp.
the Indonesia Sea scalaranes (109–114) [40]
Northern Madagascar homoscalarane sesterterpenes (115–119) [41]
the South China Sea fatty acids (120, 123), steroids (121, 122,124–127), phylloamide A (128) [42,43]
Philippines carteriosulfonic acids A–C (129–131) [44]
Fiji sesterterpene (132) [45]
2.1. Phyllospongia dendyi
One new C22 furanoterpene, furodendin (1), was characterized from P. dendyi collected near
Cairns on the Great Barrier Reef together with two known C26 tetracyclic sesterterpenes (2, 3) in
1980 [9]. One specimen of P. dendyi collected from the coasts of Andaman and Nicobar Islands in the
Indian Ocean was found to produce three novel scalaranes (4–6) and a known sesterterpene (7) [10].
Fifteen brominated compounds, bromophenols (8–12) [11] and diphenyl ethers (13–22) [12], were
detected in P. dendyi grown at Palau Islands (Chart 1). To the best of our knowledge, P. dendyi is the
only sponge that metabolizes brominated compounds among the Phyllospongia genus. Bioassay results
suggested that these bromides have a broad spectrum of biological activities, including antimacroalgal
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After Kikuchi  et  al.  firstly  reported  the  isolation  of  one  novel  anti‐inflammatory  scalarane 
bishomosesterterpene  foliaspongin  (23)  from  the  Okinawan  P.  foliascens  in  1981  [13],  two  new 
scalarane‐type bishomosesterterpenes, dehydrofoliaspongin  (24)  and phyllofoliaspongin  (25), and 













and  identified  7  compounds: phylloketal  (28)  [15], phyllofenone A  (29)  [16], phyllofenone B  (30), 
phyllofolactones  A–B  (31–32)  [17],  and  phyllohemiketal  A‐B  (33–34)  [18].  Among  these  secondary 




with  the  same  IC50  value  of  20  μg/mL.  Interestingly,  phyllactones  F–G  (41–42)  [21]  and 
phyllofolactones C–D (43–44) [22] were also detected in the same specimen. Phyllofolactone L (45) 
and phyllofenone D–E (46–47) belong to ascalarane sesterterpenoids [23]. Their chemical structures 
were  elucidated  on  the  basis  of  spectroscopic  analysis.  A  biological  assay  showed  that  only 
Chart 1. Chemical structures of secondary metabolites (1–22) from P. dendyi.
2.2. Phyllospongia (syn. Carteriospongia) foliascens
Marine sponge P. foliascens is the most productive maker of secondary metabolites among all
known Phyllospongia spp. Chemical investigation indicates that most of these compounds belong
to scalarane sesterterpenoid. P. foliascens grows in many marine areas, such as Okinawa, the South
China Sea, Papua New Guinea, Indonesia, the South Pacific near Vanuatu, and the Great Barrier
Reef. Interestingly, the same species of marine sponge collected from different areas possesses various
scalarane sesterterpenoids.
After Kikuchi et al. firstly reported the isolation of one novel anti-inflammatory scalarane
bi homos sterterpene foliaspongi (23) from the Okinawan P. foliascens in 1981 [13], two new
scalarane-type bishomosesterterpenes, dehydrofoliaspongin (24) and phyllofoliaspongin (25), an two
new furanoterpenes, dihydrofurospongin-2 (26) and furospongin-1 (27), were also characterized from
Okinawan P. foliascens (Chart 2). Compound 25 exhibited a broad spectrum of pharmacological effects,
such as cytotoxic, anti-thrombocyte, and vasodilative activities [14].
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with  the  same  IC50  value  of  20  μg/mL.  Interestingly,  phyllactones  F–G  (41–42)  [21]  and 
phyllofolactones C–D (43–44) [22] were also detected in the same specimen. Phyllofolactone L (45) 
and phyllofenone D–E (46–47) belong to ascalarane sesterterpenoids [23]. Their chemical structures 
were  elucidated  on  the  basis  of  spectroscopic  analysis.  A  biological  assay  showed  that  only 
Chart 2. Chemical structures of secondary metabolites (23–27) from P. foliascens.
Natural products from the marine sponge P. foliascens c llected from the South China Sea are
abundant. Sinc 1989, up to 36 compounds have been reported. In 199 , Fu and his coworkers isolated
and identified 7 compounds: phylloketal (28) [15], phyllofeno e A (29) [16], phyllofenone B (30),
phyllof lactones A–B (31–32) [17], and phyllohemiketal A-B (33–34) [18]. Among these econdary
metabolites, co pound 29 sh wed weak antifu gal activity against Candida pseudotropicalis, while
compound 30 displayed cytotoxic activity against the P388 murine leukemia cell line with an IC50 value
of 5 µg/mL. Acetoxy phyllofolact ne A (35) [19] and phyllactones A–E (36–40) [20] were found and
characterized in 1992. Compounds 36 and 37 had moderate in vitro cytotoxicity against KB cells with
the same IC50 value of 20 µg/mL. Interestingly, phyllactones F–G (41–42) [21] and phyllofolactones
C–D (43–44) [22] were also detected in the same specimen. Phyllofolactone L (45) and phyllofenone
D–E (46–47) belong to ascalarane sesterterpenoids [23]. Their chemical structures were elucidated on
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the basis of spectroscopic analysis. A biological assay showed that only compound 47 had moderate
cytotoxic activity against the leukemia cell line P388, with an IC50 value of 6.5 µg/mL. Two new
sesquiterpenes, phyllofolactone F (48) and phyllofolactone G (49), together with phyllofenone D (46)
and phyllofenone E (47), were isolated and identified by chromatographic methods and modern
analytical methods [7]. Carteriofenones A–C (50–52) were 20,24-bishomo-25-norscalaranes and
carteriofenones D–K (53–60) and one analogue (61) belong to 20,24-bishomoscalaranes [24]. Moreover,
phyllofolactone M (62) and a new sterol, (24E)-5α,6α-epoxystigmasta-7,24(28)-dien-3β-ol (63), together
with a known sesterterpene, phyllofolactone B (32), were detected in the same sample collected from
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Chart 3. Chemical structures of secondary metabolites (28–63) from P. foliascens. Chart 3. Chemical structures of secondary metabolites (28–63) from P. foliascens.
Mar. Drugs 2017, 15, 12 5 of 10
Seven 20,24-dimethylscalarane derivatives (64–70) were characterized from P. (syn. Carteriospongia)
foliascens gathered from Papua New Guinea. Compounds 64 and 70 were C-14 anomers [26,27].
Chemical investigation of P. (syn. C.) foliascens collected from the Indonesian sea afforded five
scalarane sesterterpenoids (71–75), which possessed Ras Converting Endoprotease (RCE) inhibitory
effect except 72 [28]. Specimens of P. (syn. C.) foliascens from the South Pacific could metabolite
12-epi-phyllofolactone B (76) [29], while the sample collected from the Great Barrier Reef produced
scalarane sesterterpenoids (77–79) [30,31]. Additionally, one furanoterpene (80) was also isolated from




foliascens  gathered  from  Papua New Guinea.  Compounds  64  and  70 were  C‐14  anomers  [26,27]. 
Chemical  investigation  of  P.  (syn.  C.)  foliascens  collected from  the  Indonesian  sea  afforded  five 
scalarane sesterterpenoids (71–75), which possessed Ras Converting Endoprotease (RCE) inhibitory 
effect except 72 [28]. Specimens of P. (syn. C.) foliascens from the South Pacific could metabolite 12‐
epi‐phyllofolactone B  (76)  [29], while  the  sample  collected  from  the Great Barrier Reef produced 
scalarane  sesterterpenoids  (77–79)  [30,31]. Additionally, one  furanoterpene  (80) was also  isolated 
from the marine sponge P. (syn. C.) foliascens [32] (Chart 4). 
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Until  now,  there  have  only  been  two  reports  on  the  chemical  study  of  the marine  sponge   




about  2  μM  [34].  From  the  same marine  sponge  derived  from  the  Egyptian  Red  Sea,  five  new 




Chart 4. Chemical structures of secondary metabolites (64–80) from P. (syn. Carteriospongia) foliascens.
2.3. Phyllospongia lamellosa
Until now, there have only been two reports on the chemical study of the marine sponge P. lamellosa
in the database Web of Sciences [33]. Five 20,24-bishomoscalane sesterterpenes, phyllolactones A–E
(81–85), were characterized from P. lamellosa collected in the Indo-West Pacific Ocean. Bioassay results
indicated that these secondary metabolites possessed an inhibitory effect on human immunodeficiency
virus type 1 (HIV-1) envelop -mediated fusion in vitro with IC50 values of about 2 µM [34]. From
the s me marin spong derived from the Egyptian Red Sea, five new scalarane sesterterpe es,
phyllospongins A–E (86–90), were detected together with four known derivatives (76, 91, 92 and 99) [8]
(Chart 5). Compounds 87–91 had potent ytotoxic activity against HCT-116 as the positive control
doxorubicin, while 90 showed cytotoxic activity against MCF-7.
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Ten  small molecules  (96–105)  (Chart 7) were  isolated  from P. papyracea  collected on Hainan 
Island in the South China Sea, Papua New Guinea, and Sangihe Island in the Indonesian Sea [36–38]. 
Cytotoxic tests suggested that compound 96 had an in vitro cytotoxic effect on the leukemia cancer cell 









Chart 5. Chemical structures of secondary metabolites (81–92) from P. lamellosa.
2.4. Phyllospongia madagascarensis
To the best of our knowledge, only three natural products (93–95) (Chart 6) have been found in
the marine sponge P. madagascarensis, which was grown near the northwest coast of Madagascar [35].
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Chart 6. Chemical structures of secondary metabolites (93–95) from P. madagascarensis.
2.5. Phyllospongia papyracea
Ten small molecules (96–105) (Chart 7) were isolated from P. papyracea collected on Hainan
Island in the South China Sea, Papua New Guinea, and Sangihe Island in the Indonesian Sea [36–38].
Cytotoxic tests suggested that co pound 96 had an in vitro cytotoxic effect on the leukemia cancer
cell li e P388 with an IC50 value of 5 µg/mL, and 99–104 were inactive against the β-catenin and
transcription factor 4 (Tcf4) c mplex. Phyllact n H (105) was found i the marine sponge derived
from Sangihe Island and possessed in vitro moderate cytotoxicities against cell lines A549, MCF-7,
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Island in the South China Sea, Papua New Guinea, and Sangihe Island in the Indonesian Sea [36–38]. 
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line  P388  with  an  IC50  value  of  5  μg/mL,  and  99–104  ere  inactive  against  the  β‐catenin  an  
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Up  to  24  secondary metabolites  (109–132)  (Chart 9) were  isolated and  identified  from other 
unclassified Phyllospongia spp. Compounds 109–114 from an Indonesian marine sponge displayed 
30%–95% inhibition of the growth of KB cells at 10 μg/mL [41]. Compounds 115–119 were produced 
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Chart 7. Chemical structures of secondary metabolites (96–105) from P. papyracea.
2.6. Carteriospongia (syn. Phyllospongia) flabellifera
The marine sponge C. (syn. P.) flabellifera is usually distributed in a wide corridor of the
Indo-Pacific Ocean. A chemical study of the marine sponge collected in the South Pacific Ocean led to
the isolation of two new small molecules, flabelliferins A (106) and B (107) [39]. Compound 106 had a
rare 25-ho cheilanthane carbon skeleton, and 107 exhibit d inhibitory effect on the human c lon
tumor cell lines KM12 and COLO205. A new sesterterp noid d ivative (108) was also characterized
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30%–95% inhibition of the growth of KB cells at 10 μg/mL [41]. Compounds 115–119 were pro uced 
by  the  Phyllospongia  sp.  collected  from  Northern  Madagascar.  Compounds  115,  116,  and  119 
possessed strong in vitro cytotoxic activities against human ovarian cancer cell line A2780  ith I 50 
val es of 0.26, 0.28, and 0.65 μM, respectively, while 117 and 118 had moderate activities with IC50 
values of 4.5 a d 8.7 μM, respectively. Compound 116 exhibited a strong  inhibitory effect on  the 
human lung non‐small cell line H522‐T1 with an IC50 value of 0.61 μM [42]. Compounds 120–127 [43] 
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Chart 8. Chemical structures of secondary metabolites (106–108) from C. (syn. Phyllospongia) flabellifera.
2.7. Other Phyllospongia spp.
Up to 24 secondary metabolites (109–132) (Chart 9) were isolated and identified from other
unclassified Phyllospongia spp. Compounds 109–114 from an Indonesian marine sponge displayed
30%–95% inhibition of the growth of KB cells at 10 µg/ L [41]. Compounds 115–119 were produced
by the Phyllospongia sp. collected from Northern Madagasc r. Compounds 115, 116, and 119 possessed
strong in vitro cytotoxic activities against human ovarian canc r cell li e A2780 with IC50 valu s of
0.26, 0.28, a d 0.65 µM, respectively, while 117 and 118 had moderate activit es with IC50 values
of 4.5 and 8.7 µM, respe tively. Compound 116 exhibit d a strong inhibitory effect on the human
lung non-sm ll cell line H522-T1 with an IC50 value of 0.61 µM [42]. Com ounds 120–127 [43] and
phylloamide A (128) [44] were also isolated from the South China Sea sponge. Carteriosulfonic acids
A–C (129–131) [45] and 132 [46] were respectively isolated from two specimens collected at Philippines
and Fiji. Bioassay results suggested that 128–130 had an inhibitory effect on the growth of glycogen
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last 37 years. Their  frameworks are diverse,  including  terpenoid, macrolide, sterol, and ceramide. 
Moreover,  the most  common  structure  is  sesterterpenoid, which has diverse biological activities. 
With  the  increasing  development  of  oceanographic  technology  leading  to  the  isolation  of  new 
Phyllospongia species from marine environments, more secondary metabolites with novel chemical 
structure(s) and/or potent bioactivities will be found in the near future. 








2. Xu, W.H.; Ding, Y.;  Jacob, M.R.; Agarwal, A.K.; Clark, A.M.; Ferreira, D.; Liang, Z.; Li, X. Puupehanol,   
a sesquiterpene‐dihydroquinone derivative  from  the marine sponge Hyrtios sp. Bioorg. Med. Chem. Lett. 
2009, 19, 6140–6143. 
Chart 9. Chemical structures of secondary metabolites (109–132) from other Phyllospongia spp.
3. Conclusions
Natural products from the marine sponge genus Phyllospongia have been well studied over the
last 37 years. Their frameworks are diverse, including terpenoid, macrolide, sterol, and ceramide.
Moreover, the most common structure is sesterterpenoid, which has diverse biological activities. With
the increasi dev lopment of oceanographic technology leading to the isolation of ew Phyllospongia
species from marine environments, more secondary metabolites with novel chemical structure(s)
and/or potent bioactivities will be found in the near future.
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